For example, an increase in the ability of microglia to recognize amyloid-beta peptide (Aβ) and abnormal aggregation of tau filaments (the cardinal features of AD) have been achieved via immunotherapy using specific antibodies (Citron, 2010; Kondo et al., 2015). Here, MAPT is linked to Alzheimer disease.